Inspire Medical Systems, Inc. Common Stock (INSP)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — May 23, 2026Investment Snapshot
- Trading 79% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -0.2%
- Revenue growing at 14% annually
Inspire Medical Systems, Inc. Common Stock (INSP) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $1.3 billion . Key value metrics: P/E ratio 45.0, P/B ratio 1.59, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Inspire Medical Systems, Inc. Common Stock — Fundamental Analysis Summary
Inspire Medical Systems, Inc. Common Stock (INSP) is currently trading 79% above its Graham Number of $24.46, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 45.0x.
On financial health, INSP shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -0.2% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.16.
StockPik's composite Value Score for INSP is 57/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
INSP reports a high gross margin of 85.3% (sector average: 40.1%) and a modest operating margin of 0.4%.
INSP shows revenue growing at 14% year-over-year, with earnings growing at 172%.